Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.019Source: DataRank Database

T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy is a research paper published in Transplantation and Cellular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 4.29)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Carla S. Walti ORCID,Kathleen Webber,G. Pezzella,Mariah Jensen-Wachspress ORCID,Haili Lang

Live enrichment

PubMed:40032074 PMC:PMC12058394 OpenAlex:https://openalex.org/W4408073124

National Institutes of Health National Cancer Institute

Grant: U01CA247548

National Institutes of Health National Cancer Institute

Grant: 5 P30 CA015704-49

NCI NIH HHS

Grant: P30 CA015704

Hyundai Hope on Wheels

National Institutes of Health

Gilead Sciences

The Mark Foundation for Cancer Research

CSL Behring

FWCI

4.29

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12058394/

publisherhttps://api.elsevier.com/content/article/PII:S266663672501053X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S266663672501053X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtct.2025.02.019

Fields of Study

CAR-T cell therapy researchBiomedical and Engineering EducationVirus-based gene therapy researchHumansInfluenza VaccinesFemaleMaleMiddle AgedAdultT-LymphocytesVaccinationReceptors, Chimeric AntigenAgedImmunotherapy, AdoptiveInfluenza, Human

MeSH Terms

Receptors, Chimeric AntigenAdultAgedFemaleHumansInfluenza, HumanInfluenza VaccinesMaleMiddle AgedT-LymphocytesVaccinationImmunotherapy, Adoptive

Keywords

Immune systemVaccinationMedicineImmunologyCellCell mediated immunityVirologyImmunityBiologyCellular immunityVaccineImmunotherapyInfluenzaCar-t

Sustainable Development Goals

SDG 0: Good health and well-being